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The Ca2+-mobilizing action of thrombin was demonstrated in a cell-free platelet membrane system consist- 
ing of open sheets of plasma membrane plus sealed membrane vesicles that accumulate Ca*+ and release 
Ca*+ in response to IP,. Thrombin plus GTP, acting on plasma membrane (not vesicles), produced a soluble 
factor (destroyed by alkaline phosphatase) that released Ca 2+ from the vesicles. This effect of thrombin/GTP 
was blocked by a monoclonal antibody that binds to vesicles and prevents Ca*+ release by IP,. Pertussis 
toxin plus NAD ADP-ribosylated plasma membrane polypeptides of 39 and 41 kDa and blocked Ca2+ re- 
lease by thronibin/GTP, but not by IP,. 
Platelet; CaZ+; Pertussis toxin; Thrombin; GTP 
1. INTRODUCTION 
Mobilization of intracellular Ca2+ in platelets 
may be mediated by the hydrolysis of plasma mem- 
brane PIP2 to form IPs [l] or cIPs [2], which can 
diffuse to the dense tubule system (smooth en- 
doplasmic reticulum) to release Ca*+ [3-51. 
Thrombin receptors may be coupled to the enzyme 
that hydrolyzes PIP2 by some type of GTP-binding 
protein (G-protein) [a], which in some cells (e.g. 
[7-9]), but not others (e.g. [lo-121) is inactivated 
by ADP-ribosylation catalyzed by pertussis toxin. 
Although thrombin causes dissociation of G- 
protein oligomers [ 131, intact platelets are not af- 
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fected by pertussis toxin presumably because they 
lack receptors for the internalization of its active 
component [ 141. Therefore, we have devised a 
novel system consisting of open plasma membrane 
sheets (accessible to the medium at both surfaces) 
and Ca’+-accumulating vesicles, which when com- 
bined together reconstitutes a GTP-dependent 
Ca’+-mobilizing action of thrombin that is inac- 
tivated by pertussis toxin. This represents, to our 
knowledge, the first demonstration of the 
Ca2+-releasing action of an agonist in a totally cell- 
free system. 
2. MATERIALS AND METHODS 
2.1. Isolation of vesicle and plasma membrane 
fractions 
Membrane vesicles derived from the platelet’s 
dense tubule system [3-51 were isolated on a 40% 
Percoll gradient as described by O’Rourke et al. 
[3]. The sealed membrane vesicles, containing the 
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highest ATP-dependent Ca*+-sequestering activity 
and response to IP3 were used as the source of the 
releasable calcium pool (i.e. fraction 4, fig.lC). 
The plasma membrane-enriched fraction was 
isolated by homogenizing washed platelets in a 
hypotonic ‘swelling’ buffer as described by Halen- 
da et al. [ 131, which produces open sheets of 
plasma membranes [15] having both external and 
cytoplasmic faces accessible to the contents of the 
medium. After centrifugation of the homogenate 
at 7000 x g for 10 min, 3.0 ml aliquots of superna- 
tant were layered over 8 ml of 25% Percoll in buf- 
fer A (100 mM KCl, 20 mM Hepes, 5 mM MgClz 
at pH 7.1) and centrifuged for 15 min at 17000 x 
g in a Sorvall centrifuge with SS-34 rotor. Frac- 
tions (1 ml) from the top of the gradient 
downwards were characterized as described below 
(sections 2.2 and 2.3). 
from plasma membrane. The Ca*+-releasing action 
of thrombin was tested as follows: 2 U/ml throm- 
bin was added for 45 s at 23°C to lOO+l aliquots 
of membranes (70-14Ogg protein), then trans- 
ferred to 0.6 ml 4sCa2+-loaded vesicles (70 pg pro- 
tein). At specified times lOO-~1 aliquots of the 
membrane-vesicle mixture were added to a ‘stop- 
ping’ solution of 25 pl of 0.63 M formalin in 
50 mM K-EDTA at pH 7.0, which immediately 
terminated release of calcium by IP3, and pre- 
vented calcium uptake, without discharging any 
Ca*+ from the vesicles. After centrifugation for 
2.5 min at 100000 x g in a Beckman airfuge, 
supernatants were removed by aspiration and the 
pellets extracted with 10% trichloroacetic acid to 
measure the 45Ca2+ by liquid scintillation spec- 
trophotometry. 
2.4. ADP-ribosylation of membranes by pertussis 
2.2. Characterization of vesicle and plasma toxin 
membrane fractions 
Vesicle and membrane fractions were assayed 
for NADPH-cytochrome c reductase, succinate 
dehydrogenase, ATP-dependent Ca*+ uptake and 
Ca*+ release by IP3, as described by O’Rourke et 
al. [3]. The binding of a monoclonal antibody 
to plasma membrane glycoprotein complex 
GpIIb/IIIa (HPla-nl, Accurate Chemical and 
Scientific Corp., NY), and a monoclonal antibody 
mAb 213121 (produced in our laboratory, un- 
published) that blocks Ca*+ release from vesicles 
by IP3, was determined by ELISAs (O’Rourke et 
al., unpublished), using as second antibodies 
affinity-purified peroxidase-labeled goat anti- 
mouse IgG (Zymed Laboratories, San Francisco, 
CA) or anti-mouse IgM (Boehringer Mannheim 
Biochemicals, Indianapolis, IN). Peroxidase ac- 
tivity was measured at 414 nm using 2,2’-azinobis- 
(3-ethylbenzthiazolinesulfonic acid) as substrate; 
endogenous peroxidase activity of membrane frac- 
tions was negligible. 
ADP-ribosylation was carried out as described 
by Halenda et al. [13], in buffer A containing 
1 mM each of: DTT, thymidine, GTP, ATP, 
EDTA, NAD and t3*P]NAD (2 Ci/mol). Op- 
timum ADP-ribosylation occurred with 50 pg/ml 
pertussis toxin; half-maximal reaction took 
S-10 min, and was 90% completed at 30 min. The 
membrane proteins were separated by SDS-PAGE 
(11% polyacrylamide gels) and 32P-labeled G- 
proteins measured by radioautography [131. 
2.5. Materials 
Inositol 1,4,5-trisphosphate (IP3) was prepared 
from red blood cells [16], or purchased from 
Amersham. Pertussis toxin was obtained from Drs 
J. Munoz (NIH, Rocky Mountain Laboratory, 
Hamilton, MT) and E.L. Becker (University of 
Connecticut Health Center), and from List 
Biochemicals (Campbell, CA). These toxin 
preparations did not differ in their effects. 
2.3. Calcium-releasing action of thrombin 
3. RESULTS AND DISCUSSION 
The vesicle fraction was loaded with calcium by 
incubation for 60 min in 100 mM KCl, 20 mM 
Hepes (free acid), 1.9 mM ATP, 5 mM MgC12, 
10 mM KH2P04 at pH 7.1, 0.4 mM CaCl2 
(4 &i/ml 45Ca2+) and 0.568 mM EGTA; free 
[Ca*‘] = 1.1 PM [3]. These vesicles served as the 
target system for potential Ca*+-releasing factors 
The plasma membrane and vesicle fractions are 
characterized in fig.1. The vesicle fraction (frac- 
tion 4 from the 40% Percoll gradient) showed 
relatively low binding of a monoclonal antibody to 
the plasma membrane glycoprotein complex 
GpIIb/IIIa, compared to lighter fractions l-3, 
and high binding of mAb 213/21 (fig.lA,B). Frac- 
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Fig.1. Characterization of vesicle and membrane fractions. Vesicle fraction: (A) binding of monoclonal antibody HPla- 
nl (vs Gp IIb/IIIa); (B) binding of antibody 213/21 (see section 2.3); (C) distribution of Ca2’ uptake (0). NADPH- 
cytochrome c reductase (0) and succinate dehydrogenase (0). Membrane fraction: (D) NADPH-cytochrome c 
reductase (0) in pooled fractions, and response to thrombin; i.e. Ca2+ -releasing activity when added to vesicles (bars). 
tion 4 contained the peak activities for Ca2+ uptake 
and NADPH-cytochrome c reductase (fig. 1C); as 
well as the peak activities for other dense tubule 
enzymes (i.e. glucose-6-phosphatase, NADH- 
cytochrome c reductase), and the greatest response 
to IPs [3]. Half-maximal response was obtained at 
0.2-0.3 /IM IP3 (fig.lA). The plasma membranes 
used in these experiments (fractions 3-4 from the 
25% Percoll gradient) did not accumulate Ca2+, 
were lowest in the dense tubule marker NADPH- 
cytochrome c reductase and had the greatest 
Ca2+-releasing response to thrombin (fig.lD). 
Binding of antibodies was similar to fractions l-2 
from the 40% Percoll gradient. 
Membrane sheets preincubated with human 
thrombin (> 1000 U/mg; US Biochemicals) plus 
GTP for 45-60 s and then added to the vesicles 
released 66% of the Ca2+ discharged from the 
same vesicles by 5 ,uM IPs (table 1). Neither throm- 
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Table 1 
Effect of thrombin and GTP on Ca2+ release from 
vesicles in the presence or absence of plasma membranes 
Ca2+ released 
(nmol/mg vesicle 
protein + SE) 
Vesicles + GTP + thrombin 1.55 f 1.55 (4) 
Vesicles + IP3 27.50 f 4.80 (6) 
Membranes plus vesicles 0.93 f 0.93 (12) 
+ GTP 1.84 f 0.94 (6) 
- GTP + thrombin 4.59 * 2.21 (5) 
+ GTP + thrombin 18.10 f 1.41 (12) 
+ IP3 24.60 f 2.45 (6) 
Vesicles took up 88.4 nmol Ca2+/mg protein. Release of 
vesicle Ca” was measured as described in section 2.3. 
Concentrations: thrombin, 2 U/ml; GTP, 1 mM; IP3, 
5 pM. Number of experiments in parentheses 
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bin nor GTP directly released CaL+ from vesicles. 
Without added GTP, thrombin-treated mem- 
branes released a small amount of Ca*+, but with 
GTP release of Ca*+ increased 4-fold (table 1). 
Pertussis toxin plus NAD abolished the plasma 
membrane response to thrombin/GTP, but not the 
direct release of Ca*+ caused by IP3 (table 2). 
Treatment of the vesicles alone with toxin plus 
NAD did not alter their response to normal throm- 
bin/GTP-stimulated membranes. The time course 
of the release of Ca*+ by thrombin/GTP is shown 
in fig.2; response was abolished only by treatment 
of the membranes with both activated toxin and 
NAD, and was associated with the ADP- 
ribosylation of two membrane polypeptides of M, 
41000 (minor band) and A4r 39000 (major band) 
(fig.2B, inset). 
Release of Ca*+ was entirely due to a soluble fac- 
tor (100000 x g supernatant) appearing in the 
medium from thrombin/GTP-treated membranes 
(fig.2D). This activity, like that of IP3, was 
abolished by incubation with 1 U/ml alkaline 
phosphatase (1100 U/mg, Sigma P-0200) for 
10 min at 23°C (not shown), suggesting that the 
Ca*+-releasing substance could be IP3 or cIP3 [2]. 
Table 2 
Inhibition of thrombin-induced, but not IP3-induced, 




protein + SE) 
Vesicles alone 
+ IPs 26.90 k 3.44 ( 8) 
+ PT (+ NAD), then IPs 20&Y * 1.81 ( 4) 
Membranes plus vesicles 
Controls, no treatment 1.33 + 0.90 ( 9) 
+PT(+NAD) 1.81 + 1.81 (11) 
+ PT (- NAD), then 
thrombin/GTP 21.30 + 3.89 ( 5) 
+ PT (+ NAD), then 
thrombin/GTP 2.70 f 0.79 ( 9) 
a Difference from control response to IP3 is not 
statistically significant 0, > 0.05) 
Vesicles took up 84.3 nmol Ca2+/mg protein. IP3,5 PM; 
thrombin, 2 U/ml; GTP, 1 mM; PT, 50pg/ml 
Fig.2. (A) Dose response for release of 45Ca2+ from 
vesicles by IPr. (B) Inhibition of thrombin-induced 
4sCa2+ release by pertussis toxin (PT): (0) membranes 
plus PT (50 fig/ml) and NAD for 30 min, then thrombin 
(2 U/ml) added for 45 s and membrane fraction 
transferred to 45Ca 2+-leaded vesicles; (0) same as above 
minus NAD; (0) 45Ca2+ release by 5 pM IP3. (Inset) 
Radioautograph of 41 kDa and 39 kDa [32P]ADP- 
ribosylated polypeptides of the membrane fraction. (C) 
Same as (B) but membranes preincubated with NAD 
plus pertussis toxin (0), or without toxin (0). (D) (0) 
Supernatant, Sn(M), from membrane fraction added to 
45Ca2+-loaded vesicles; (0) supernatant, Sn(M + Thr), 
from membranes treated with 2.0 U/ml thrombin/ 
1 mM GTP for 45 s added to 45Ca2+-loaded vesicles. (0) 
Thrombin added to 45Ca2+-loaded vesicles. (E) Throm- 
bin/GTP-stimulated membranes added at arrow to 
control vesicles (o), or vesicles preincubated with 75 nM 
mAb 213/21 (0). 
Furthermore, release of Ca*+ by thrombin/GTP- 
treated membranes was also blocked by treatment 
of vesicles (but not membranes) with mAb 213121, 
an antibody that blocks the action of IP3 (fig.2E). 
These findings are consistent with the report that 
thrombin/GTP stimulates IP3 formation by 
isolated platelet membranes 171. 
[ 191 found that thrombin-induced Ca*+ 
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release was inhibited 45% by the toxin (19 pg/ml, 
30 min). Our model system of plasma membrane 
sheets and Ca2+-loaded vesicles, which provides a 
novel means to explore both the mechanism of ac- 
tion of thrombin and the role of G-proteins, clear- 
ly shows: (i) that GTP greatly enhances the 
Ca2+-releasing action of thrombin, and (ii) that 
maximal ADP-ribosylation of G-proteins by per- 
tussis toxin (50/1g/ml, 30 min) completely blocks 
the response to thrombin/GTP. Further work is 
necessary to characterize the proteins ADP- 
ribosylatable by pertussis toxin and their role in 
stimulus-response coupling in platelets. 
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